Your browser is no longer supported. Please, upgrade your browser.
BNGO Bionano Genomics, Inc. daily Stock Chart
Bionano Genomics, Inc.
Index- P/E- EPS (ttm)-2.70 Insider Own16.20% Shs Outstand26.84M Perf Week17.89%
Market Cap30.06M Forward P/E- EPS next Y-0.64 Insider Trans0.00% Shs Float21.58M Perf Month24.58%
Income-28.30M PEG- EPS next Q-0.18 Inst Own9.90% Short Float13.26% Perf Quarter5.77%
Sales11.40M P/S2.64 EPS this Y25.30% Inst Trans28.48% Short Ratio0.53 Perf Half Y-59.86%
Book/sh-0.68 P/B- EPS next Y69.00% ROA-114.70% Target Price3.00 Perf Year-83.53%
Cash/sh0.31 P/C3.67 EPS next 5Y- ROE- 52W Range0.50 - 8.00 Perf YTD-78.63%
Dividend- P/FCF- EPS past 5Y- ROI-107.00% 52W High-86.00% Beta-
Dividend %- Quick Ratio2.00 Sales past 5Y- Gross Margin29.00% 52W Low124.00% ATR0.12
Employees77 Current Ratio2.40 Sales Q/Q17.90% Oper. Margin- RSI (14)57.53 Volatility10.16% 13.05%
OptionableNo Debt/Eq- EPS Q/Q-19.60% Profit Margin- Rel Volume0.68 Prev Close1.09
ShortableYes LT Debt/Eq- EarningsNov 07 AMC Payout- Avg Volume5.39M Price1.12
Recom- SMA2014.01% SMA5020.80% SMA200-54.51% Volume3,677,954 Change2.75%
Dec-05-19 11:56AM  Benzinga Pro's Top 5 Stocks To Watch For Thurs., Dec. 5, 2019: KR, YETI, BNGO, GOOS, ULTA Benzinga +19.13%
08:00AM  Breakthrough Findings in Leukemias Presented at ASH 2019 Demonstrate Bionano Saphyrs Potential to Replace All Cytogenetic Methods and Show Additional Clinical Utility GlobeNewswire
Nov-14-19 09:00AM  Bionano Genomics, Inc. (BNGO) Upgraded to Buy: What Does It Mean for the Stock? Zacks +8.38%
Nov-12-19 08:00AM  Takeaways from AMP 2019 in Baltimore: Users of Bionanos Saphyr System Presented Results from Multiple Studies Demonstrating the Systems Utility for a Variety of Disease Indications GlobeNewswire +24.05%
Nov-07-19 04:01PM  Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire +13.46%
07:18AM  The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs Benzinga
Nov-06-19 06:03PM  Novogene Adopts Bionanos Saphyr System Adding Saphyrs Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of Services GlobeNewswire +10.99%
Nov-04-19 05:16PM  Bionano Genomics to Report Third Quarter 2019 Financial Results and Host a Conference Call and Webcast on November 7 GlobeNewswire
Oct-24-19 08:00AM  Takeaways from ASHG 2019 in Houston: Users of Bionanos Saphyr System Presented Validation Results for FSHD, Repeat Expansion Disorders and Digital Cytogenetics Among a Growing List of Applications of Saphyr in Human Genetics and Cancer Research GlobeNewswire -8.18%
Oct-21-19 09:27AM  Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering GlobeNewswire -43.16%
Oct-16-19 08:00AM  Bionano Genomics Announces Adoption of Its Saphyr® System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for Clinical Testing GlobeNewswire +417.62%
12:12AM  Top Researchers to Present Discoveries Made Possible by Bionanos Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual Meeting GlobeNewswire
Sep-20-19 06:56AM  What Kind Of Shareholder Owns Most Bionano Genomics, Inc. (NASDAQ:BNGO) Stock? Simply Wall St. -7.56%
Sep-09-19 08:00AM  Bionano Genomics to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-30-19 08:00AM  Bionano Genomics Releases Users Video Presentations of Preliminary Data Affirming Saphyr's Potential to Replace Traditional Cytogenetics Methods in Certain Blood Cancers GlobeNewswire
Aug-13-19 08:00AM  Preliminary Data Confirm Saphyrs Potential to Replace Traditional Cytogenetics Methods for Detection of Structural Variants in Certain Blood Cancers GlobeNewswire
Aug-08-19 04:05PM  Bionano Genomics Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -5.18%
Aug-02-19 08:00AM  Bionano Genomics to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 8 GlobeNewswire
Jun-19-19 02:19PM  How Much Are Bionano Genomics, Inc. (NASDAQ:BNGO) Insiders Spending On Buying Shares? Simply Wall St. -5.28%
Jun-17-19 08:00AM  Results Presented at ESHG 2019 Showcase the Advantages of Saphyr over Traditional Cytogenetics Methods for the Detection of Structural Variants in Patients with Genetic Disease and Cancer GlobeNewswire -11.03%
Jun-14-19 08:00AM  Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics Conference GlobeNewswire
Jun-13-19 08:00AM  Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital Cytogenetics GlobeNewswire +9.06%
Jun-12-19 08:30AM  Bionano Genomics Appoints Kristiina Vuori, MD, PhD, to its Board of Directors GlobeNewswire
May-09-19 04:01PM  Bionano Genomics Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -5.67%
May-03-19 08:00AM  Bionano Genomics to Report First Quarter 2019 Financial Results and Host a Conference Call and Webcast on May 9 GlobeNewswire
Apr-17-19 12:00PM  Consortium Study Finds Bionano Genomics Optical Mapping Essential for Comprehensive Detection of Structural Variants GlobeNewswire
Mar-18-19 08:00AM  Bionano Genomics to Present at the 31st Annual ROTH Conference GlobeNewswire
Mar-14-19 05:18PM  Bionano Genomics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018 Business Wire
05:18PM  Bionano Genomics Enters Into Debt and Equity Financing Agreements Totaling $41.5 Million in Commitments Business Wire
Mar-11-19 09:17PM  Bionano Genomics to Report Fourth Quarter and Fiscal Year 2018 Financial Results and Host a Conference Call and Webcast on March 14, 2019 GlobeNewswire -5.24%
Mar-06-19 04:01PM  Bionano Genomics to Present at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Mar-05-19 08:00AM  The Largest Study Conducted with Bionanos Platform to Date Reveals Never-Before-Seen Human Genomic Structural Variations GlobeNewswire +19.32%
Mar-01-19 08:00AM  Bionano Genomics Launches New Capabilities of the Saphyr System to Significantly Increase Its Cost Effectiveness, Speed and Ease of Use for Whole Human Genome Structural Variation Analysis and Digital Cytogenetics GlobeNewswire
Feb-06-19 02:20PM  These 4 Biotech Stocks Are Leading The Industry ACCESSWIRE +11.29%
08:00AM  Bionano Genomics Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot GlobeNewswire
Jan-14-19 08:00AM  Global Adoption of Bionano Genomics Saphyr® System Accelerating for Clinical Genomics Applications GlobeNewswire -7.02%
Nov-23-18 02:10PM  What does Bionano Genomics Incs (NASDAQ:BNGO) Balance Sheet Tell Us About Its Future? Simply Wall St.
Nov-13-18 08:15AM  Report: Exploring Fundamental Drivers Behind CCA Industries, Goodrich Petroleum, Intelligent, China Automotive, Bionano Genomics, and Gates Industrial New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-07-18 04:01PM  Bionano Genomics Releases Operating Results for Third Quarter 2018 GlobeNewswire
Oct-25-18 07:25PM  Bionano Genomics to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018 GlobeNewswire
Oct-19-18 08:51PM  UPDATE GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China GlobeNewswire
04:14PM  GrandOmics Biosciences Offers Genetic Test Using the Saphyr System for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) in China GlobeNewswire
Oct-17-18 11:00AM  Bionano and Genoox Launch Integrated Platform for Identification of Structural Variants in DNA GlobeNewswire
Oct-16-18 03:00PM  Bionano Genomics Structural Variation Results Presented at ASHG 2018 Provide Insights in Cancer and Genetic Disease GlobeNewswire
Sep-21-18 08:00AM  Bionano Genomics Announces the Separate Trading of Its Common Stock and Warrants GlobeNewswire
Aug-15-18 07:17AM  BioNano Genomics to offer 2.45 million shares in IPO priced at $6 to $7 each MarketWatch
Jul-30-18 04:33PM  The IPO Outlook For The Week: A Light Slate Of Tech, Real Estate Benzinga
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.